Research Group Roberto Speck

Our research initiative in the field of experimental HIV medicine is highly active and focuses primarily on immunotherapy and the development of an HIV‐resistant immune system through gene engineering. We also dedicate ourselves to the genetic modification of monocytes/macrophages for cancer combat. We employ a wide range of in vitro and in vivo methods for these purposes. Our overarching goal is to gain a profound understanding of HIV pathogenesis and the complex immune network, expand the possibilities of gene manipulation, and simultaneously provide preclinical evidence for the feasibility of future clinical studies.

Professor Dr. Speck’s laboratory is well‐integrated into the research landscape of Zurich and greatly benefits from its unique scientific richness. In particular, we would like to highlight our vibrant international collaborations, where we work with Professor Dr. Oliver Keppler from LMU Munich (Germany), Prof. PhD Benjamin Berkhout and PhD Elena Herrera Carrillo from UMC Amsterdam (Netherlands), PD Dr. Klaus‐Peter Knobeloch from the University of Freiburg (Germany), Prof. Dr. Giuseppe Pantaleo, Dr. Craig Fenwick, and Dr. Yannick Muller from CHUV Lausanne (Switzerland).

Our laboratory receives generous financial support from various foundations, including the Swiss National Foundation, the Swiss Vaccine Institute, and the VonTobel Foundation.